Kyle Piskel Adaptive Biotechnologies Corp (ADPT) insider trading activity
Kyle Piskel is Chief Financial Officer of Adaptive Biotechnologies Corp. Currently has a direct ownership of 269,010 shares of ADPT, which is worth approximately $1.98 Million. The most recent transaction as insider was on Mar 05, 2025, when has been sold 10,320 shares (Common Stock) at a price of $6.98 per share, resulting in proceeds of $72,033. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
269K
74.31%
3M change
118.14%
12M change
Total Value Held
$1.98 Million
KYLE PISKEL Transaction History
KP
Kyle Piskel
Chief Financial Officer
Seattle, WA